Related Experiment Videos

Clinical Images:Lupus erythematosus cells in the kidney and synovial fluid

B M Atiquzzaman¹, D D Ricciardi, Y Yazici

¹Long Island College Hospital, Brooklyn, NY, USA.

Arthritis and Rheumatism

|February 24, 2001

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis.

Osteoarthritis and cartilage·2021

Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment.

Osteoarthritis and cartilage·2019

A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee.

Osteoarthritis and cartilage·2017

A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study.

Osteoarthritis and cartilage·2017

Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone.

Scandinavian journal of rheumatology·2015

Results of a questionnaire on the treatment of patients with Behçet's syndrome: a trend for more intensive treatment.

Clinical and experimental rheumatology·2012

See all related articles